论文部分内容阅读
目的:探讨盐酸氨溴索辅助治疗支气管肺炎的临床分析。方法:回顾性分析我我中心2014年1月~在2015年1月收治的支气管炎患儿90例,按照随机数字法将全部患者分为对照组和研究组,对照组在常规治疗的基础上予α-糜蛋白酶1支加入0.9%氯化钠注射液5ml,高频雾化吸入,2次/d,研究组在常规治疗的基础上实施盐酸氨溴索辅助治疗,比较两组患者的疗效及体征消失的时间。结果:研究组总有效率为95.56%,对照组患者的总有效率为84.44%,研究组总有效率显著优于对照组,差异有显著性(p<0.05)。研究组患者发热消失、咳嗽消失、湿性啰音消失的时间均显著低于对照组,差异有显著性(p<0.05)。结论:盐酸氨溴索用于小儿支气管肺炎的治疗,可迅速缓解临床症状,改善通气功能和呼吸状况,效果较好,安全可靠,值得临床推广应用。
Objective: To investigate the clinical analysis of ambroxol hydrochloride in the treatment of bronchial pneumonia. Methods: A retrospective analysis of 90 patients with bronchitis in our center from January 2014 to January 2015 was performed. According to random number method, all patients were divided into control group and study group. On the basis of routine treatment, To 1ml of chymase plus 0.9% sodium chloride injection 5ml, high-frequency inhalation, 2 times / d, the study group on the basis of routine treatment of ambroxol hydrochloride adjuvant therapy, the efficacy of the two groups were compared And the disappearance of signs of time. Results: The total effective rate was 95.56% in the study group and 84.44% in the control group. The total effective rate in the study group was significantly better than that in the control group (p <0.05). The study group patients disappeared fever, cough disappeared, wet rales disappeared significantly lower than the control group, the difference was significant (p <0.05). Conclusion: Ambroxol hydrochloride for the treatment of children with bronchial pneumonia, can quickly relieve clinical symptoms and improve ventilation and respiratory status, the effect is better, safe and reliable, worthy of clinical application.